middle.news
Firebrick Pharma Accelerates Growth with Nasodine Throat Spray Launch and 15% Sales Boost
8:32am on Wednesday 28th of January, 2026 AEDT
•
Healthcare
Read Story
Firebrick Pharma Accelerates Growth with Nasodine Throat Spray Launch and 15% Sales Boost
8:32am on Wednesday 28th of January, 2026 AEDT
Key Points
Nasodine Throat Spray enters commercial manufacturing and Singapore market
TGA export approval secured, with first orders received in Fiji
User survey shows 96% effectiveness rating and 97% ease of use for Nasodine Nasal Spray
15% year-on-year growth in cash sales, driven by US market expansion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
FIREBRICK PHARMA (ASX:FRE)
OPEN ARTICLE